Communication from the Dignitana AB Annual General Meeting 2018

Lund, Sweden – 24 April 2018 – Dignitana AB, has today held an annual general meeting at the company's premises in Lund. In all the proposed cases, the AGM resolved in accordance with the Board's proposal. Below is a summary of the decisions taken. 

The AGM resolved to adopt the income statement and balance sheet included in the annual report.

The meeting resolved to allocate the profit for the year in accordance with the board of directors’ proposal, entailing the profit for the year to be carried forward.

The meeting resolved to adopt the income statement and balance sheet included in the annual report.

The meeting resolved to allocate the profit for the year in accordance with the board of directors’ proposal, entailing the profit for the year to be carried forward.

The meeting resolved to discharge the board members and managing director from liability for their management of the company’s affairs during the preceding financial year.

It was resolved that the board fee shall be paid at 100 000 SEK to Ingrid Atteryd Heiman and Mikael Wahlgren and that no board fee shall be paid to William Cronin and Thomas Kelly for the assignment in Dignitana AB.

William Cronin, Thomas Kelly, Mikael Wahlgren and Ingrid Atteryd Heiman are re-elected for the period until the next annual general meeting.

Current audit firm PricewaterhouseCoopers is re-elected.

The meeting authorized the board of directors to be able to decide, during the period up to the next annual general meeting, to issue shares with or without deviation from the shareholders’ preferential rights according to proposal from the board, Appendix 2. 

The meeting decided on an incentive program, including a directed issue of synthetic options to employees in the group according to proposal from the board, Appendix 3



This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 1758 (CET), 24 April 2018

Investor Relations

Melissa Bourestom                                       

Dignitana                                                       

00 1 773 387 8504                                         

investorrelations@dignitana.com                 

Media Contact   

Caren Browning  

King + Company

00 1 212 561 7464

caren.browning@kingcompr.com

About Dignitana AB (publ)

Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. DigniCap is a patented scalp cooling system that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort.

 For more information visit www.dignitana.se  and www.dignicap.com.

Tags:

About Us

Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. DigniCap®is a patented scalp cooling system that offers cancer patients with solid tumors the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. For more information visit www.dignitana.se and www.dignicap.com.

Subscribe

Documents & Links